MIM
CDLX icon

Monashee Investment Management’s Cardlytics CDLX Stock Holding History

Monashee Investment Management’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-7,500
Closed -$1.09M – 88
2024
Q1 		$1.09M Buy
+7,500
New +$633K 0.13% 89
2019
Q4 		– Sell
-13,050
Closed -$4.37M – 90
2019
Q3 		$4.37M Buy
13,050
+11,550
+770% +$3.7M 1.99% 17
2019
Q2 		$390K Sell
1,500
-2,000
-57% -$400K 0.1% 123
2019
Q1 		$579K Buy
+3,500
New +$569K 0.13% 106
2018
Q3 		– Hold
0
– – – 85

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PIP
PB Investment Partners Burlingame, California $127M AUM 0.83% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return
BCM
Brightlight Capital Management Westport, Connecticut $101M AUM 23.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Monashee Investment Management's CDLX Position: Q2 2024 in Review

Monashee Investment Management sold out of Cardlytics (CDLX) in Q2 2024, closing a stake of 7,500 shares — an estimated $1.09M sold.

Monashee Investment Management first reported a position in CDLX in Q1 2019 and held it in 4 quarters. The position peaked at $4.37M in Q3 2019. 127 funds tracked by Wall St. Rank hold CDLX as of Q2 2024.

  • Monashee Investment Management reported no remaining Cardlytics position as of Q2 2024 after selling out during the quarter.
  • Monashee Investment Management sold 7,500 Cardlytics shares in Q2 2024, an estimated $1.09M.
  • Monashee Investment Management first reported a position in Cardlytics in Q1 2019 and held it in 4 quarters.
  • Monashee Investment Management's Cardlytics position peaked at $4.37M in Q3 2019.
  • 127 funds tracked by Wall St. Rank held Cardlytics as of Q2 2024.

Based on Monashee Investment Management's 13F filing for Q2 2024, filed 12 Aug 2024.